Fact.MR forecasts a 7.0% CAGR through 2036 as cloud LIMS adoption, regulatory requirements, and laboratory digitisation shape demand.

ROCKVILLE, MD — October 1, 2026 — The Enterprise Laboratory Informatics Market is projected to reach USD 19.8 billion by 2036, rising from an estimated USD 6.6 billion in 2026 at a 7.0% CAGR, according to Fact.MR analysis. The market was valued at USD 6.0 billion in 2025 and is expected to generate an additional USD 13.2 billion between 2026 and 2036.

Demand is being shaped by increasing drug development activity, stricter requirements for electronic records, and wider adoption of digital laboratory workflows. At the same time, high validation and compliance costs continue to slow cloud adoption in regulated environments, while legacy systems and lengthy procurement processes delay implementation.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=14623

The covers software platforms and services used to manage laboratory workflows, scientific data, electronic records, and data integrity. The scope includes LIMS, ELN, CDS, EDC, CDMS, LES, ECM, and SDMS across pharmaceutical, biotechnology, CRO, chemical, food, and industrial laboratories.

Fact.MR is a market research and advisory company that provides market forecasts, industry analysis, and strategic intelligence based on primary and secondary research.

LIMS Holds 20% Share as Software Takes 65%

LIMS is expected to hold 20% of the enterprise laboratory informatics market in 2026, according to Fact.MR. It remains a core system for sample tracking, compliance, and laboratory data management. Many laboratories adopt LIMS before adding ELN or SDMS modules.

Software is projected to account for 65% share in 2026. Fact.MR attributes this position to SaaS subscriptions and recurring licence revenue, with buyers seeking continuing software updates and AI-enabled features.

The shift toward cloud and hybrid architectures is also changing purchasing patterns. Fact.MR identifies hybrid cloud as an increasingly common model, allowing sensitive data to remain on-premise while analytics move to cloud environments.

Regulatory Changes Reshape Cloud LIMS Adoption

FDA Computer Software Assurance guidance issued in 2025 is identified by Fact.MR as a factor supporting risk-based validation and reducing validation workload. The report cites a 61% validation burden reported by pharmaceutical firms, highlighting one of the pressures affecting software implementation.

China is another major source of demand. Updated NMPA requirements for electronic records and audit trails are driving first-time LIMS and ELN adoption across 4,500+ pharmaceutical firms, according to Fact.MR.

The report also tracks regulatory developments under FDA 21 CFR Part 11, EU GMP Annex 11, China NMPA requirements, India CDSCO Schedule M, and Australia TGA guidance.

For further context on software assurance requirements, Fact.MR references the [LINK: FDA Computer Software Assurance guidance] in its research methodology and regulatory analysis.

China and India Show Double-Digit Growth

China is projected to record a 10.2% CAGR from 2026 to 2036, the highest among the countries highlighted by Fact.MR. NMPA electronic-record requirements, CRO expansion, and biotech investment are contributing to demand for validated LIMS and ELN systems.

India follows with a 10.0% CAGR. Updated Schedule M requirements are supporting informatics upgrades across pharmaceutical manufacturing sites, while domestic pharmaceutical companies and CROs continue investing in laboratory infrastructure.

Germany is forecast to expand at 9.4% CAGR, supported by EU Annex 11 compliance requirements and pharmaceutical site upgrades. The United States is projected to grow at 8.9% CAGR, while Australia and Japan are expected to record CAGRs of 8.5% and 8.2%, respectively.

Cloud Migration Meets Legacy-System Constraints

Large pharmaceutical companies continue to operate validated on-premise LIMS, creating high switching costs. Cloud-native platforms can offer faster deployment, but validation requirements remain a practical consideration for regulated laboratories.

Shambhu Nath Jha, Principal Consultant at Fact.MR, said the research examines the cloud LIMS migration decision, the effect of FDA Computer Software Assurance guidance on validation costs, and procurement cycles across industry verticals.

“Cloud LIMS adoption is closely tied to how laboratories manage validation requirements,” said Shambhu Nath Jha, Principal Consultant at Fact.MR. “The changing regulatory environment is reducing some barriers, while legacy systems still influence implementation decisions.”

Fact.MR also identifies AI-based anomaly detection and predictive maintenance as technology developments being incorporated into laboratory informatics platforms. LabVantage 8.9 and Agilent upgrades are cited in the report as examples of this direction.

“The market is moving toward more integrated platforms,” said Shambhu Nath Jha, Principal Consultant at Fact.MR. “LIMS remains central, but laboratories are increasingly looking at connected modules, cloud deployment and AI features.”

Competitive Activity Expands Across Informatics Platforms

The market includes established vendors such as LabWare, LabVantage Solutions, Inc., Agilent Technologies, Inc., Waters Corporation, LabLynx, Inc., Dassault Systèmes SE, LABWORKS LLC, Autoscribe Informatics, PerkinElmer, Inc., and Accelerated Technology Laboratories.

Fact.MR also tracks Thermo Fisher Scientific, Benchling, and Dotmatics in its competitive analysis. The report highlights platform integration, AI module development, cloud deployment, and acquisition activity as areas shaping competition.

Fact.MR's research uses a hybrid top-down and bottom-up approach based on LIMS software revenue, SaaS adoption rates, laboratory site counts, pharmaceutical R&D spending, compliance-program timelines, vendor financial disclosures, and primary interviews with laboratory informatics procurement and validation specialists.

View Related Reports :

https://social.mytamam.com/blogs/44424/Semiconductor-Diffusion-Equipment-Market-Set-to-Grow-at-8-4

https://www.panchit.com/blogs/107351/Welding-Equipment-Market-Arc-Welding-Holds-48-Product-Share

https://uddokta64.com/blogs/9848/Metal-Casting-Market-Growth-Supported-by-EV-and-Industrial-Demand 

https://gulfsena.com/blogs/99329/Switch-Mode-Power-Supply-Transformers-Market-Outlook-5-09-Billion

About Fact.MR

Fact.MR is a market research and advisory firm providing industry intelligence, market forecasts, and strategic analysis across global markets. Its research combines primary interviews, regulatory sources, company disclosures, and quantitative market modelling.